It is increasingly recognized that
vitamin D deficiency is associated with increased risks of metabolic disorders among
overweight children. A recent study showed that
vitamin D deficiency exacerbated
inflammation in
nonalcoholic fatty liver disease through activating
toll-like receptor 4 in a high-fat diet (HFD) rat model. The present study aimed to further investigate the effects of
vitamin D deficiency on HFD-induced
insulin resistance and hepatic
lipid accumulation. Male ICR mice (35 d old) were randomly assigned into 4 groups as follows. In control diet and
vitamin D deficiency diet (VDD) groups, mice were fed with purified diets. In HFD and VDD+HFD groups, mice were fed with HFD. In VDD and VDD+HFD groups,
vitamin D in feed was depleted. Feeding mice with
vitamin D deficiency diet did not induce
obesity,
insulin resistance, and hepatic
lipid accumulation. By contrary,
vitamin D deficiency markedly alleviated HFD-induced
overweight,
hyperinsulinemia, and hepatic
lipid accumulation. Moreover,
vitamin D deficiency significantly attenuated HFD-induced up-regulation of hepatic
peroxisome proliferator-activated receptor γ, which promoted hepatic
lipid uptake and lipid droplet formation, and its target gene cluster of differentiation 36. In addition,
vitamin D deficiency up-regulated
carnitine palmitoyltrans 2, the key
enzyme for
fatty acid β-oxidation, and
uncoupling protein 3, which separated oxidative phosphorylation from
ATP production, in adipose tissue. These data suggest that
vitamin D deficiency is not a direct risk factor for
obesity,
insulin resistance, and hepatic
lipid accumulation.
Vitamin D deficiency alleviates HFD-induced
overweight,
hyperinsulinemia, and hepatic
lipid accumulation through promoting
fatty acid β-oxidation and elevating energy expenditure in adipose tissue.